Streetbeat News

Stock Prices

CNTM

ConnectM Technology Solutions reported a Q2 2024 EPS of $(0.39), a significant decline compared to $0.84 in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:18 pm

SURG

Surgepays (NASDAQ:SURG) reported a significant decline in its Q2 2024 financial performance, with a GAAP EPS of $(0.66), down 265% from $0.40 YoY, and sales of $15.086M, missing the $15.154M estimate and down 57.96% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:17 pm

INTZ

Intrusion Inc. (INTZ) has announced that it is well-positioned to improve its financial performance in future periods. The company is optimistic about its growth prospects.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:16 pm

CCL

Recent options trading activity for Carnival (NYSE: CCL) shows a mix of bullish and bearish sentiment among big-money investors. Benzinga's options scanner identified 8 unusual trades, with a total of $259,498 in calls and $131,388 in puts. Analysts have mixed ratings on the stock, with price targets ranging from $15 to $25.

Portfolio Pulse from Benzinga Insights

August 13, 2024 | 8:16 pm

INTZ

Intrusion (NASDAQ:INTZ) reported Q2 2024 GAAP EPS of $(0.53), beating the estimate of $(0.55). Sales were $1.46M, surpassing the $1.18M estimate. This represents a 0.54% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:15 pm

XCUR

Exicure (NASDAQ:XCUR) reported a significant improvement in its Q2 earnings per share (EPS), with losses narrowing to $(0.07) from $(0.68) in the same period last year, representing an 89.71% increase.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:15 pm

KRRO

Korro Bio (NASDAQ:KRRO) reported a Q2 EPS of $(2.43), missing the analyst consensus estimate of $(2.40) by 1.25%. This represents a 96.19% improvement over the $(63.83) per share loss from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:14 pm

TNON

Tenon Medical (NASDAQ:TNON) reported Q2 2024 GAAP EPS of $(1.02), beating the estimate of $(1.08). However, sales of $901K missed the $909.5K estimate. Sales increased by 21.27% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:14 pm

CTSO

CytoSorbents (NASDAQ:CTSO) reported Q2 2024 GAAP EPS of $(0.08), beating the $(0.10) estimate. Sales were $9.895M, surpassing the $9.678M estimate and showing a 5.03% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:13 pm

RVYL

RYVYL shares are trading lower following a Q2 earnings and revenue miss.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:13 pm